Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Syneos Health Inc
(NQ:
SYNH
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 27, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Syneos Health Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Syneos Health's Debt Overview
November 04, 2022
Over the past three months, shares of Syneos Health Inc. (NASDAQ:SYNH) decreased by 62.76%. Before having a look at the importance of debt, let's look at how much debt Syneos Health has.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 04, 2022
Gainers
Via
Benzinga
Looking Into Syneos Health's Recent Short Interest
November 04, 2022
Syneos Health's (NASDAQ:SYNH) short percent of float has risen 25.38% since its last report. The company recently reported that it has 1.67 million shares sold short, which is 1.63% of all regular...
Via
Benzinga
Nasdaq Turns Lower; Crude Oil Rises Sharply
November 04, 2022
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 04, 2022
Gainers Incannex Healthcare (NASDAQ:IXHL) shares moved upwards by 30.7% to $5.19 during Friday's pre-market session. The market value of their outstanding shares is at $316.2 million.
Via
Benzinga
Expert Ratings for Syneos Health
October 05, 2022
Analysts have provided the following ratings for Syneos Health (NASDAQ:SYNH) within the last quarter:
Via
Benzinga
Analyst Ratings for Syneos Health
September 12, 2022
Within the last quarter, Syneos Health (NASDAQ:SYNH) has observed the following analyst ratings:
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
November 04, 2022
Friday's session saw 236 companies set new 52-week lows.
Via
Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
November 04, 2022
Gainers
Via
Benzinga
Why Starbucks Shares Are Trading Higher; Here Are 43 Stocks Moving Premarket
November 04, 2022
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares rose 67.7% to $5.10 in pre-market trading after jumping 24% on Thursday.
Via
Benzinga
Syneos Health Reports Third Quarter 2022 Results
November 04, 2022
From
Syneos Health, Inc.
Via
GlobeNewswire
Earnings Outlook For Syneos Health
November 03, 2022
Syneos Health (NASDAQ:SYNH) is set to give its latest quarterly earnings report on Friday, 2022-11-04. Here's what investors need to know before the announcement. Analysts estimate that Syneos Health...
Via
Benzinga
Earnings Scheduled For November 4, 2022
November 04, 2022
Companies Reporting Before The Bell • Sprott (NYSE:SII) is likely to report quarterly earnings at $0.49 per share on revenue of $49.95 million. • Telefonica (NYSE:TEF) is likely to report earnings for...
Via
Benzinga
Syneos Health Adds HUB Patient Suite to Deployment Solutions Business
October 27, 2022
Brings Together the Industry’s Most Comprehensive Suite of Modular Patient Services, Optimizing Patient Experience from Prescription to Adherence
From
Syneos Health, Inc.
Via
GlobeNewswire
Syneos Health Schedules Third Quarter 2022 Earnings Call for Friday, November 4, 2022
October 21, 2022
From
Syneos Health, Inc.
Via
GlobeNewswire
Syneos Health Appoints William E. Klitgaard Independent Director
October 14, 2022
From
Syneos Health, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
October 18, 2022
Upgrades
Via
Benzinga
Syneos Health Wins Triangle Business Journal 2022 Leaders in Diversity Award
October 13, 2022
From
Syneos Health, Inc.
Via
GlobeNewswire
Syneos Health Expands Partnership with Datavant to Accelerate Delivery of New Therapies to Patients
October 11, 2022
Collaboration Streamlines Clinical Trial Tokenization, Further Empowers Medical Affairs, Market Access, HEOR and Commercial Analytics for Clients
From
Syneos Health, Inc.
Via
GlobeNewswire
Citigroup Maintains Neutral Rating for Syneos Health: Here's What You Need To Know
October 05, 2022
Citigroup has decided to maintain its Neutral rating of Syneos Health (NASDAQ:SYNH) and lower its price target from $70.00 to $55.00. Shares of Syneos Health are trading down 3.28% over the last 24...
Via
Benzinga
Syneos Health Releases Annual Sustainability Report
October 05, 2022
Report Spotlights Significant Progress Toward Achieving Company’s Environmental, Social and Governance Goals, Including Climate Pledge and DE&I Objectives
From
Syneos Health, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
September 19, 2022
On Monday, 429 stocks made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 16, 2022
During Friday's session, 574 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 15, 2022
On Thursday, 191 stocks hit new 52-week lows.
Via
Benzinga
Tesla, Meta, NVIDIA And Other Big Losers From Tuesday
September 14, 2022
U.S. stocks closed sharply lower with the Nasdaq Composite dipping more than 5% on Tuesday. Here is the list of some big stocks moving lower in the previous session.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
September 14, 2022
During Wednesday's session, 265 companies made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 13, 2022
On Tuesday, 126 companies set new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
September 07, 2022
Upgrades
Via
Benzinga
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
September 14, 2022
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.